Kaiming Sun

Kaiming Sun is a seasoned expert in translational medicine with extensive experience across various biotechnology and pharmaceutical companies. Currently serving as a consultant for Relay Therapeutics and Myrobalan Therapeutics, Kaiming has previously held leadership roles, including Vice President of Translational Sciences at Nested Therapeutics and Evive Biotech. With a strong focus on biomarker development and clinical strategies, Kaiming has contributed to numerous successful projects, including the clinical development of niraparib at GSK and significant advancements at TESARO, Curis, and Aileron Therapeutics. Kaiming holds a Ph.D. in Molecular and Cellular Biology from Brandeis University.